Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases

被引:0
|
作者
Kihara, Sayaka [1 ,2 ]
Ohira, Shingo [1 ,3 ]
Kanayama, Naoyuki [1 ]
Ikawa, Toshiki [1 ]
Inui, Shoki [1 ]
Isono, Masaru [1 ]
Nitta, Yuya [1 ]
Ueda, Yoshihiro [1 ]
Nishio, Teiji [2 ]
Konishi, Koji [1 ]
机构
[1] Osaka Int Canc Inst, Dept Radiat Oncol, 3-1-69 Otemae,Chuo Ku, Osaka 5418567, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Med Phys Lab, Osaka, Japan
[3] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan
来源
IN VIVO | 2025年 / 39卷 / 01期
关键词
Stereotactic radiosurgery; brain metastases; HyperArc; volumetric modulated arc therapy; linear accelerator; RADIOSURGERY;
D O I
10.21873/invivo.13819
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: HyperArc (HA) is an automated planning technique enabling single-isocenter brain stereotactic radiotherapy (SRT); however, dosimetric outcomes may be influenced by the planner's expertise. This study aimed to assess the impact of institutional experience on the plan quality of HA-SRT for both single and multiple brain metastases. Materials and Methods: Twenty patients who underwent HASRT for single metastasis between 2020 and 2021 comprised the earlier group, while those treated between 2022 and 2024 constituted the later group. For multiple metastases, 40 patients who received HA-SRT from 2020 2024 were divided into earlier and later treatment groups. Dosimetric parameters including gross tumor volume (GTV) doses (D98% and Dmean), volumes of the normal brain (Brain-GTV V25Gy and V30Gy), homogeneity index (HI), gradient index (GI), and total monitor unit (MU) were compared. A linear regression model was used to evaluate the effects of planning target volume (PTV) on volumes of normal brain via interaction between PTV volume and treatment era group (earlier vs. later). Results: The later group exhibited significantly higher D98% and Dmean values for both single and multiple metastases, while V25Gy and V30Gy and GI mean values were comparable. Consequently, mean HI and total MU values increased significantly. Both single and multiple metastases showed significant interaction between PTV volume and treatment era group. Conclusion: Enhanced dosimetric outcomes in the later group suggested that accumulated experience contributed to improve GTV and brain dose in HA SRT. Institutional experience is important to improve the plan quality for SRT even with automatic planning such as HA.
引用
收藏
页码:210 / 217
页数:8
相关论文
共 50 条
  • [31] STEREOTACTIC RADIOSURGERY AND STEREOTACTIC RADIOTHERAPY FOR PEDIATRIC BRAIN METASTASES OR RECURRENCES
    McGovern, Susan
    Mackin, Dennis
    Li, Jing
    Paulino, Arnold
    Grosshans, David
    Weinberg, Jeffrey
    Sandberg, David
    Chintagumpala, Murali
    Gill, Jonathan
    Zaky, Wafik
    Briere, Tina
    McAleer, Mary Frances
    NEURO-ONCOLOGY, 2022, 24 : 177 - 177
  • [32] Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
    Benkhaled, Sofian
    Schiappacasse, Luis
    Awde, Ali
    Kinj, Remy
    CANCERS, 2024, 16 (06)
  • [33] Dosimetric Comparison between Cyberknife and Linac Based Hyperarc Stereotactic Radiosurgery for Brain Metastases
    Singh, K. K.
    Cao, J.
    MEDICAL PHYSICS, 2024, 51 (10) : 7952 - 7952
  • [34] Hypofractionated Stereotactic Radiotherapy for the Treatment of Brain Metastases
    Kwon, Alexander K.
    DiBiase, Steven J.
    Wang, Brian
    Hughes, Samuel L.
    Milcarek, Barry
    Zhu, Yunping
    CANCER, 2009, 115 (04) : 890 - 898
  • [35] Dynamic trajectory radiotherapy versus HyperArc: treatment plan comparisons for tumors in the brain
    Manser, Peter
    Manser, P.
    Mueller, S.
    Frei, D.
    Volken, W.
    Terribilini, D.
    Frauchiger, D.
    Joosten, A.
    Henzen, D.
    Herrmann, E.
    Aebersold, D. M.
    Fix, M. K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1131 - 1132
  • [36] Stereotactic radiotherapy of brain metastases in elderly patients
    Astner, S. T.
    Arnold, T. E.
    Andratschke, N.
    Molls, M.
    Grosu, A. -L
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 68 - 69
  • [37] Stereotactic radiotherapy of brain metastases in complex situations
    Noel, G.
    Keller, A.
    Antoni, D.
    CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 708 - 715
  • [38] Stereotactic radiotherapy for large solitary brain metastases
    Feuvret, L.
    Vinchon, S.
    Martin, V.
    Lamproglou, I.
    Halley, A.
    Calugaru, V.
    Chea, M.
    Valery, C. A.
    Simon, J. -M.
    Mazeron, J-J
    CANCER RADIOTHERAPIE, 2014, 18 (02): : 97 - 106
  • [39] Radionecrosis after stereotactic radiotherapy for brain metastases
    Le Rhun, E.
    Dhermain, F.
    Vogin, G.
    Reyns, N.
    Metellus, P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (08) : 903 - 914
  • [40] Preoperative stereotactic radiotherapy for the management of brain metastases
    Biau, Julian
    Guillemin, Florent
    Ginzac, Angeline
    Villa, Julie
    Truc, Gilles
    Antoni, Delphine
    Le Fevre, Clara
    Thillays, Francois
    CANCER RADIOTHERAPIE, 2024, 28 (6-7): : 534 - 537